Article Details
Retrieved on: 2021-08-03 19:32:08
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Hummerson reflected that when he joined the biopharmaceutical industry in 2006, developers of monoclonal antibodies (MAbs) expressed great need ...
Article found on: bioprocessintl.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here